Megan Quella
Family · Springfield, MONPI 1194356535
Payments from drug & device makers
Across 66 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$255
- AstraZeneca$202
- Amgen$202
- Lilly USA, LLC$105
- Dexcom, Inc.$105
- Otsuka America Pharmaceutical, Inc.$70
- plus $505 from 20 others
What the payments were for
- Food & beverage$1,445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $255 |
| AstraZeneca | 5 | $202 |
| Amgen | 11 | $202 |
| Lilly USA, LLC | 7 | $105 |
| Dexcom, Inc. | 7 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Insulet Corporation | 2 | $69 |
| Boehringer Ingelheim | 3 | $51 |
| Sanofi-aventis U.S. LLC | 1 | $46 |
| Bayer | 2 | $32 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Lundbeck LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Radius Health, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Medtronic | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| AbbVie | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$1,445 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $36,360 |
| JardianceEmpagliflozin | 43 | $34,603 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $18,494 |
| TrulicityDulaglutide | 14 | $15,571 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $15,140 |
| FarxigaDapagliflozin Propanediol | 18 | $11,443 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $11,300 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $9,607 |
| Humalog Kwikpen U-100Insulin Lispro | 23 | $7,425 |
| Novolog FlexpenInsulin Aspart | 25 | $5,132 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 16 | $3,041 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,899 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 13 | $1,947 |
| Tizanidine Hcl | 29 | $1,428 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 14 | $1,045 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $255 | $36,36029 claims |
| Boehringer IngelheimJardiance | $51 | $34,60343 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $202 | $21,05129 claims |
| Lilly USA, LLCTrulicity | $105 | $15,57114 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $46 | $11,30011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.
Other family in Springfield
- Laura HedigerSpringfield$71K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.